- Conditions
- Adenotonsillar Hypertrophy, Obstructive Sleep Apnea, Sleep-Disordered Breathing, Acute Post Operative Pain
- Interventions
- Ketorolac
- Drug
- Lead sponsor
- St. Louis University
- Other
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 142 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
Source: ClinicalTrials.gov public record
Updated Feb 2, 2025 · Synced May 22, 2026, 4:13 AM EDT